Arani N, Rausch CR, Geppner A, Borthakur G, et al. Cladribine and venetoclax combined with alemtuzumab in patients with relapsed/refractory T-cell prolymphocytic leukemia. Leuk Lymphoma 2025 Oct 22:1-5. doi: 10.1080/10428194.2025.2566318.
PMID: 41124080